Haiyan Zeng, MD, is a promising young radiation oncologist and PhD candidate at Maastricht University, the Netherlands. She is passionate about improving cancer care through translational and clinical research, with a focus on brain metastases and neurocognitive impairment in patients with lung cancer. Dr. Zeng received her medical degree from Nanchang University in China in 2012 as an “Outstanding graduate”. She obtained her Master's Degree at the University of Jinan in 2017 with her thesis being awarded as the "Outstanding Master's Thesis of University of Jinan" and "Outstanding Master's Thesis of Shandong Province," and she was further recognized with the "Scientific Innovative Awards of Jinming Yu" in 2018. She is an active member of several oncology organizations, including ESMO, ESTRO, and IASLC. She is expected to obtain her Ph.D. from Maastricht University in June 2023. She has given several abstract presentations at international conferences, such as three oral presentations at ESTRO (2021, 2023), a poster presentation at ESMO 2022, one ePoster at WCLC 2022 and one poster at WCLC 2021. She has published articles and correspondences in peer-reviewed journals, including some high-impact journals (such as Journal of Clinical Oncology, Lancet Oncology) and open access journals (Such as JAMA Network Open).
Haiyan Zeng, MD, is a promising young radiation oncologist and PhD candidate at Maastricht University, the Netherlands. She is passionate about improving cancer care through translational and clinical research, with a focus on brain metastases and neurocognitive impairment in patients with lung cancer. Dr. Zeng received her medical degree from Nanchang University in China in 2012 as an “Outstanding graduate”. She obtained her Master's Degree at the University of Jinan in 2017 with her thesis being awarded as the "Outstanding Master's Thesis of University of Jinan" and "Outstanding Master's Thesis of Shandong Province," and she was further recognized with the "Scientific Innovative Awards of Jinming Yu" in 2018. She is an active member of several oncology organizations, including ESMO, ESTRO, and IASLC. She is expected to obtain her Ph.D. from Maastricht University in June 2023. She has given several abstract presentations at international conferences, such as three oral presentations at ESTRO (2021, 2023), a poster presentation at ESMO 2022, one ePoster at WCLC 2022 and one poster at WCLC 2021. She has published articles and correspondences in peer-reviewed journals, including some high-impact journals (such as Journal of Clinical Oncology, Lancet Oncology) and open access journals (Such as JAMA Network Open).